Temsirolimus
Orphan Drug Cold Chain RequiredFDA Approved
Contents
Description
Temsirolimus is an mTOR inhibitor used in the treatment of advanced renal cell carcinoma. It inhibits mTOR, a protein that regulates cell growth, proliferation, and survival.
Indications & Therapeutic Use
Advanced renal cell carcinoma
Linked Diseases:
renal cell carcinoma
C64D002292
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Temsirolimus — GNH India
7 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Temsirolimus products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Temsirolimus
| Generic Name | Temsirolimus |
| Brands | 1 brand available |
| Active Ingredient | Temsirolimus |
| Drug Class | Advanced renal cell carcinoma |
| Manufacturer | Pfizer |
| Dosage Forms | IV infusion |
| Medical Code | L01XE09 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Reg. Status | FDA Approved |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes